Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nolan M. Priedigkeit"'
Autor:
Zheqi Li, Olivia McGinn, Yang Wu, Amir Bahreini, Nolan M. Priedigkeit, Kai Ding, Sayali Onkar, Caleb Lampenfeld, Carol A. Sartorius, Lori Miller, Margaret Rosenzweig, Ofir Cohen, Nikhil Wagle, Jennifer K. Richer, William J. Muller, Laki Buluwela, Simak Ali, Tullia C. Bruno, Dario A. A. Vignali, Yusi Fang, Li Zhu, George C. Tseng, Jason Gertz, Jennifer M. Atkinson, Adrian V. Lee, Steffi Oesterreich
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-18 (2022)
Mutations of ESR1, the gene encoding the estrogen receptor alpha, are associated with acquired resistance to therapy in luminalbreast cancer. Here the authors show that ESR1 mutant tumors gain basal-like features with increased expression of basal cy
Externí odkaz:
https://doaj.org/article/3ce70acd6e2e4c66a89d08122c1ec702
Autor:
Steffi Oesterreich, Adrian V. Lee, Jennifer M. Atkinson, Peter C. Lucas, Ben H. Park, Jens-Uwe Blohmer, Maria M. Karsten, Carsten Denkert, Paul Jank, Jason S. Carroll, Nikhil Wagle, George C. Tseng, Li Zhu, Elena Guerini-Rocco, Caterina Fumagalli, Simon C. Watkins, Callen T. Wallace, Prithu Sundd, Maritza A. Montanez, Massimo Cristofanilli, Youbin Zhang, Lorenzo Gerratana, Qiang Zhang, Dorraya El-Ashry, Benjamin Troness, Jennifer K. Richer, Jason Gertz, Spencer Arnesen, Laki Buluwela, Simak Ali, Azadeh Nasrazadani, Nolan M. Priedigkeit, Kevin M. Levine, Jian Chen, Amir Bahreini, Nilgun Tasdemir, Megan E. Yates, Yang Wu, Zheqi Li
Supplementary Data from Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11b63c7d873493580bae33876033436b
https://doi.org/10.1158/0008-5472.22431151
https://doi.org/10.1158/0008-5472.22431151
Autor:
Steffi Oesterreich, Adrian V. Lee, Jennifer M. Atkinson, Peter C. Lucas, Ben H. Park, Jens-Uwe Blohmer, Maria M. Karsten, Carsten Denkert, Paul Jank, Jason S. Carroll, Nikhil Wagle, George C. Tseng, Li Zhu, Elena Guerini-Rocco, Caterina Fumagalli, Simon C. Watkins, Callen T. Wallace, Prithu Sundd, Maritza A. Montanez, Massimo Cristofanilli, Youbin Zhang, Lorenzo Gerratana, Qiang Zhang, Dorraya El-Ashry, Benjamin Troness, Jennifer K. Richer, Jason Gertz, Spencer Arnesen, Laki Buluwela, Simak Ali, Azadeh Nasrazadani, Nolan M. Priedigkeit, Kevin M. Levine, Jian Chen, Amir Bahreini, Nilgun Tasdemir, Megan E. Yates, Yang Wu, Zheqi Li
Constitutively active estrogen receptor α (ER/ESR1) mutations have been identified in approximately one-third of ER+ metastatic breast cancers. Although these mutations are known as mediators of endocrine resistance, their potential role in promotin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2f3cbfdf669ffc0225f181ab59c07b4
https://doi.org/10.1158/0008-5472.c.6513817
https://doi.org/10.1158/0008-5472.c.6513817
Autor:
Zheqi Li, Yang Wu, Olivia Mcginn, Amir Bahreini, Nolan M. Priedigkeit, Kai Ding, Sayali Onkar, Carol A. Sartorius, Lori Miller, Margaret Rosenzweig, Nikhil Wagle, Jennifer K. Richer, William J. Muller, Laki Buluwela, Simak Ali, Dario A.A. Vignali, Yusi Fang, Li Zhu, George C. Tseng, Jason Gertz, Jennifer M. Atkinson, Adrian V. Lee, Steffi Oesterreich
Publikováno v:
Cancer Research. 82:PD1-08
Estrogen receptor alpha (ER/ESR1) is mutated in 30-40% of endocrine resistant ER-positive (ER+) breast cancer. ESR1 mutations cause ligand-independent growth and increased metastasis in vivo and in vitro. Despite the distinct clinical features and ch
Autor:
Zheqi Li, Yang Wu, Megan E. Yates, Nilgun Tasdemir, Amir Bahreini, Jian Chen, Kevin M. Levine, Nolan M. Priedigkeit, Azadeh Nasrazadani, Simak Ali, Laki Buluwela, Spencer Arnesen, Jason Gertz, Jennifer K. Richer, Benjamin Troness, Dorraya El-Ashry, Qiang Zhang, Lorenzo Gerratana, Youbin Zhang, Massimo Cristofanilli, Maritza A. Montanez, Prithu Sundd, Callen T. Wallace, Simon C. Watkins, Caterina Fumagalli, Elena Guerini-Rocco, Li Zhu, George C. Tseng, Nikhil Wagle, Jason S. Carroll, Paul Jank, Carsten Denkert, Maria M. Karsten, Jens-Uwe Blohmer, Ben H. Park, Peter C. Lucas, Jennifer M. Atkinson, Adrian V. Lee, Steffi Oesterreich
Publikováno v:
Cancer Res
Constitutively active estrogen receptor α (ER/ESR1) mutations have been identified in approximately one-third of ER+ metastatic breast cancers. Although these mutations are known as mediators of endocrine resistance, their potential role in promotin
Publikováno v:
PLoS ONE, Vol 5, Iss 9 (2010)
The tumor suppressor KLF6 and its oncogenic cytoplasmic splice variant KLF6-SV1 represent a paradigm in cancer biology in that their antagonistic cancer functions are encoded within the same gene. As a consequence of splicing, KLF6-SV1 loses both the
Externí odkaz:
https://doaj.org/article/605a1bbc64e442fb83ea1c10b13678cd